INS and Hyperglycemia: The injection of rAAV-lep increases hypothalamic leptin expression and moderates diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance (Buettner et al., 2000; Bagnasco et al., 2003; Lee et al., 2004).